Insider Trading & Ownership of Paul J. Clancy

Location
Madison, WI
Summary
The estimated net worth of Paul J. Clancy is at least $2,468,228 dollars as of 02 Apr 2026. Paul J. Clancy is the Director of INCYTE CORP and owns shares of INCYTE CORP (INCY) stock worth about $2.34M. Paul J. Clancy is the Director of AGIOS PHARMACEUTICALS, INC. and owns shares of AGIOS PHARMACEUTICALS, INC. (AGIO) stock worth about $123.3K.
Signature
/s/ Elizabeth Feeney, Attorney-In-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Paul J. Clancy and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Quick Takeaways

  • Paul J. Clancy has 5 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $2,468,228.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: INCYTE CORP ($2,344,898).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Paul J. Clancy

INCY Forms 3/4/5

INCYTE CORP

Relationship
Director
Holdings value
$2,344,898
Past year net change
Change %
Report period
31 Mar 2026

Insider Transactions Reported by Paul J. Clancy:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .